Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-051191
Filing Date
2021-08-12
Accepted
2021-08-12 17:26:18
Documents
1
Period of Report
2021-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6700
  Complete submission text file 0001209191-21-051191.txt   8048
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Azamian Bobak R. (Reporting) CIK: 0001827672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 211168851